BioNexus Gene Lab Corp. (BGLC) vs Senestech, Inc. (SNES)
BioNexus Gene Lab Corp. and Senestech, Inc. are both Specialty Chemicals companies. BioNexus Gene Lab Corp. is the larger, with a market value of $4.3M against $3.9M — 1.1× the size. Senestech, Inc. grew revenue faster over the last twelve months: 13.4% against −67.3%. BioNexus Gene Lab Corp. has the higher net margin (−82.4% vs −294.7%) and the higher return on invested capital (−37.2% vs −416.4%). Across the 19 metrics below, BioNexus Gene Lab Corp. leads on 12 and Senestech, Inc. on 7.
Valuation
Profitability
| Metric | BGLC | SNES | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 12.34% | 66.18% | 29.23% |
| Operating margin | (79.62%) | (303.66%) | 3.63% |
| Net margin | (82.36%) | (294.73%) | 2.89% |
| Free cash flow margin | (27.30%) | (281.42%) | 3.78% |
| Return on equity | (33.66%) | (107.41%) | 3.62% |
| Return on assets | (28.38%) | (70.73%) | 0.35% |
| Return on invested capital | (37.16%) | (416.42%) | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack